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Abstract
Background: Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is a rare inherited disease. In most
HAE-affected subjects, defined trigger factors precede angioedema attacks. Mechanisms of how trigger factors
stimulate the contact activation pathway with bradykinin generation are not well elucidated. In recent studies,
hypersensitivity reactions and food were stated as relevant triggers. We investigated HAE affected people for
possible hypersensitivity reactions or intolerances and their relation in triggering angioedema attacks.
Methods: A questionnaire was filled in, recording date of birth, gender, and self-reported angioedema attacks
associated with the ingestion of foodstuffs, administration of drugs, hymenoptera stings and hypersensitivity reactions
against inhalation allergens. All participants performed a skin prick test against inhalation allergens and food. In patients
who stated an association of possible hypersensitivity with angioedema, a serological ImmunoCAP test was also
performed.
Results: From the 27 women and 15 men analyzed, 79% stated trigger factors. From those food was mentioned in 36%.
The suspected food included tomato, green salad, fish, citrus fruits, apple, onion, garlic, cheese, chili, kiwi, milk, tree nuts,
strawberry, pineapple, shrimps, bread, banana, leek, chicken and alcohol, and were associated with abdominal angioedema.
Neither the skin prick test nor the ImmunoCAP-test turned out positive for the tested food allergens.
Conclusion: Food seems to be a relevant trigger factor, causing angioedema in HAE affected patients. The reason,
however, is not IgE-mediated hypersensitivity, but most probably an intolerance reaction to food products.
Keywords: Hereditary angioedema (HAE), Trigger factors, Allergy, Intolerance
Background
Hereditary angioedema with C1 inhibitor deficiency
(C1-INH-HAE) is a rare inherited disease, due to muta-
tions of the SERPING1 gene. Two different variants have
been described. Type I is characterized by a quantitative
decrease in C1-INH protein, in Type II, the C1-INH
protein has a normal level, but is dysfunctional [1, 2].
C1-INH inhibits factors of the contact system including
FXII and kallikrein, and controls the generation of vaso-
active peptides such as bradykinin [3]. C1-INH-HAE is
characterized by episodic attacks of subcutaneous and
submucosal swelling affecting extremities, trunk, geni-
tals, and face, and might be life threatening when upper
airways and abdomen are affected [4, 5]. Although it is a
systemic activation process, frequency and localization
of angioedema are highly variable, depending on the
trigger factors and the upregulation of bradykinin recep-
tors 1 and 2 (B1R, B2R) on the endothelium [6, 7]. In 56
to 91% of HAE-affected subjects, defined factors or cir-
cumstances may trigger angioedema attacks [8, 9]. The
most frequent trigger factors are emotions, mechanical
trauma, infections, and, in women, hormonal causes,
such as menstruation, pregnancy or intake of estrogen
pills. In recent studies food ingestion has also been sug-
gested to cause angioedema attacks in HAE [8–10].
Mechanisms of how food could trigger angioedema
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attacks have not yet been elucidated. Patients who are
affected by angioedema induced by food, drugs or
hymenoptera stings interpret the cause most often as an
IgE-mediated hypersensitivity reaction. Recent studies
have demonstrated an interaction of activated mast cells
by an allergen and the contact activation pathway resul-
ting in the production of bradykinin [11–13].
The aim of this study was to evaluate the influence of
atopy or IgE-mediated hypersensitivity reactions to specific
food, drugs or hymenoptera stings on angioedema attacks
in HAE affected subjects. We assessed the prevalence of
atopy in 42 HAE affected patients in correlation with the
frequency of angioedema attacks and investigated trigger
factors including food, drugs or hymenoptera venoms for
specific IgE antibodies.
Methods
Patients
Patients from the Division of Haematology of the
Cantonal Hospital Lucerne and from the Allergy
Units of the University Hospitals of Berne and Zurich
were included. They all fulfilled the diagnostic criteria
for HAE [1]. All patients included are part of the
Swiss HAE cohort study [9].
A questionnaire was sent to all participants: patients’
personal data, details of hypersensitivities/intolerances
and symptoms (e.g.rhinoconjunctivitis, asthma, vomit-
ing, stomach pain, diarrhea) were recorded. All partici-
pating patients gave their written informed consent. The
protocol of this study received Ethics Committee ap-
proval from the Northwest - and Central Switzerland
ethics committee. The study was conducted according
to the principles of good clinical practice and adhered
strictly to the ethical standards outlined in the Declar-
ation of Helsinki [14].
Skin tests
Skin prick tests (SPT) with 7 commercially available aero-
allergens (birch, ash, grass, mugwort, Alternaria alternata,
house dust mite and cat dander) and 13 food antigen
extracts (soy, hen’s egg, cow’s milk, celery, apple, codfish,
shrimp, peanut, walnut, curry, chili, rye flour, and wheat
flour) were tested (ALK-Abello, Hørsholm, Denmark). For
banana and pine apple a prick-to-prick test was per-
formed. If the wheal diameter was ≥3 mm the test reaction
was considered to be positive as recommended in the
European standards for skin prick testing [15].
For the SPT with medications the drug powder dis-
solved in 0.9% saline was applied onto the skin of the
forearms. If a wheel of at least 5 mm in diameter with
surrounding erythema after 20 min was evident, the test
was found positive [16].
Serologic tests
Serum samples were tested with the multitest Phadiatop
Sx1 (timothy grass, birch, cultivated rye, mugwort, dog
dander, cat dander, Cladosporium herbarum, D. pteronyssi-
nus) and the multitest Fx5 (egg white, cow’s milk, fish (cod),
wheat flour, peanut, soy bean). Specific IgE (sIgE) and total
IgE were determined by ImmunoCAP FEIA (Thermo Fisher
Scientific/Phadia, Uppsala, Sweden) according to the manu-
facturer’s directions for use. SIgE levels > 0.35 kUA/L (RAST
class ≥1) were considered positive. In one patient IgA and
anti-transglutaminase IgA was performed (Thermo Fisher
Scientific/Phadia, Uppsala, Sweden).
Data handling
Clinical information was collected in each study center
and transmitted to the administration site of the respon-
sible researcher. Data were entered into the electronic
database. If data were incomplete, the participant was
contacted for specific clarification. The final dataset was
pseudonymised and prepared for analysis. The pseudo-
nymisation key is stored at the administration site.
For evaluating attack frequency we considered the re-
sults from the Swiss HAE cohort study [9] and assumed
that sensitization patterns and attack frequency at the
time point of the 2012-evaluation were stable.
Results
The analysis was based on 42 consenting patients (27
women and 15 men) with a mean age of 45 years (SD
16.1), all completed the questionnaire, conducted a skin
test and consented to provide blood samples.
Trigger factors
Trigger factors causing HAE were indicated by 79% (23
women, 10 men). The most frequent trigger was emo-
tion with 79.% (18 women, 8 men) followed by trauma
with 55% (12 women, 6 men) food 36% (10 women, 2
men), drugs 6% and hymenoptera stings 6% with 2
women each. Patient characteristics and trigger factors
are presented in Table 1.
Atopy in HAE affected patients
Atopy documented by positive skin prick tests was iden-
tified in 29% (9 women, 3 men). Grass and tree pollen
were the most prevalent allergen sources, followed by
house dust mites, cat dander and mugwort. Ten of the
12 sensitized subjects were symptomatic with rhinocon-
junctivitis (Table 1).
Association of self-reported hypersensitivity- or
intolerance reaction and angioedema
Trigger factors were interpreted by the subjects them-
selves in 57% (11 women, 2 men), as an IgE-mediated
hypersensitivity reaction. Four of these 13 subjects were
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indeed confirmed to be atopic (Tables 1 and 2). In all
the twelve subjects with food as a trigger, abdominal an-
gioedema was induced. The included food were tomato
(1), green salad (1), fish (2), citrus fruits (2), apple (3),
onion (3), garlic (3), cheese (2), chili (2), kiwi (1), milk
(3), tree nut (1), peanut (1), strawberry (2), pineapple (3),
shrimps (1), bread (1), banana (1), leek (1), chicken (1),
chamomile (1) and alcohol (1). However skin prick test
for the specific food was negative in all 12 participants
and none of the 11/12 tested patients with multitest fx5
and single food proteins had specific IgE (Table 2). Two
women each mentioned bee/wasp venom, and drugs as
a trigger. No specific IgE to the recombinant venom
allergens of Api m1, Api m10 or Vesv5 were detected. In
the two subjects with assumed drug induced angio-
edema, SPT of acetylsalicylic acid (ASS) in one and ASS
combinations Pretuval®, NeoCitran® and the antidepres-
sant Deroxat® (paroxetin) in the other patient resulted
negative. Drug intake was not concomitant with reac-
tions to hymenoptera venoms (Table 2). Four subjects
complained of urticarial episodes. One atopic patient
suffered from acute urticaria, 3 non atopic patients
suffered from acute, inducible (physical) and aspirin
induced urticaria (AIU) each. The one with AIU
mentioned an association with urticaria and HAE typical
angioedema. The other three did not observe an associ-
ation between their urticaria and angioedema.
Frequency of angioedema in atopic and non-atopic
subjects
There was no difference in the incidence of HAE attacks
in atopic and non-atopic subjects (Table 3).
Discussion
We investigated 42 participants (31%) of the Swiss HAE
cohort for suspected self-reported hypersensitivity or
intolerance reactions as trigger factors for their angio-
edema attacks [9]. The majority of the participating indi-
viduals (79%) stated that trigger factors preceded
angioedema attacks. Emotions, followed by trauma, were
mentioned most frequently, which is in line with the
current literature [8, 9]. Hypersensitivities or intoler-
ances to food, medications or hymenoptera stings were
stated by almost half of the patients with trigger factors
(Table 1).
IgE-mediated hypersensitivity with mast cell activation
can be associated with heparin release and a consequent
bradykinin generation [11–13, 17, 18]. Almost one third
of our cohort was atopic. This proportion reflects the
general population’s prevalence of atopy in Northern
Europe and in industrialized countries [19–21]. In our
cohort no difference of attack frequency was docu-
mented between atopic and non atopic subjects. With
regard to the question of whether suspected hypersensi-
tivity or intolerance is associated with angioedema, there
was no relevant difference between atopic (33%)
compared to non-atopic subjects (30%). Based on our
data, atopy does not predispose HAE affected subjects to
suffer from more frequent angioedema attacks (Table 3).
Interestingly in all 12 subjects the specific food which
was mentioned as a trigger factor seemed to induce abdo-
minal angioedema attacks (Table 2). However, in none of
them specific IgE against the indicated food products could
be documented, neither by SPT nor by serological tests.
Therefore, food induced abdominal angioedema attacks in
these subjects are triggered most probably by an intolerance
reaction due to unknown mechanisms. Most of the food
mentioned by the investigated subjects such as cheese, alco-
holic beverages, fish, tomatoes, strawberries, pineapples,
nuts, citrus fruits and kiwis contain or release histamine
[22]. Therefore a histamine intolerance reaction is probably
associated with the induction of angioedema. However, a
clear allocation of food inducing histamine intolerance re-
mains difficult and a reliable laboratory test for objective
diagnosis is lacking [23–25]. Three patients suffered from a
known lactose intolerance and they stated a clear
Table 1 Characteristics of 42 patients
Parameter Number (men/women)
Patients 42 (15/27)
mean age (years) 45 (SD 16.1)
HAE variants
Type I 41 (0/41)
Type II 1 (1/0)
Trigger factors
Emotions 26 (8/18)
Trauma / Mechanical trigger 18 (6/12)
Hormonesa 17 (0/17)
Infection 13 (3/10)
Food 12 (2/10)
Drugs 2 (0/2)
Bee/Wasp sting 2 (0/2)
Total 33 (10/23)
Atopy
Patients 12 (3/9)
Grass pollen 10 (1/9)
Tree pollen 10 (3/7)
House dust mite 5 (2/3)
Cat dander 3 (1/2)
Mugwort 3 (1/2)
Self reported hypersensitivities/intolerances inducing angioedema
Atopic 4 (0/4)
Non atopic 9 (2/7)
amenstruation, pregnancy or intake of estrogen pills
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association between HAE attacks and intake of cow’s milk
products. In lactose intolerance the unabsorbed lactose
leads to osmotic diarrhea and gas production causing flatu-
lence and abdominal pain. In these subjects also a height-
ened activity of the innate mucosal immune system with
increased counts of mast cells and lymphocytes is described
[26, 27]. Which of these mechanisms are influencing the
formation of angioedema in HAE remains to be analyzed
further. For one subject, who declared bread as a cause of
angioedema celiac disease was excluded with a negative test
for anti-tissue transglutaminase IgA-antibodies.
This study corroborates that food is a relevant trigger
factor for abdominal angioedema attacks in HAE
affected subjects. However the underlying pathomechan-
isms for activation of the contact activation pathway
with bradykinin formation in the investigated subjects
seem to be intolerance reactions rather than
IgE-mediated hypersensitivity. In these patients a careful
individual nutritional counseling is recommended with
the aim of a targeted avoidance of the food concerned.
Little data are available on urticaria in HAE [28, 29].
The prevalence of urticaria in our cohort was 10%. This
proportion was lower compared to the general popula-
tion or a recently described survey of a HAE cohort,
which is most probably explained by the small number
of our investigated population [28, 30].
An association of urticaria with typical HAE was only
corroborated by the patient with AIU. Acute and physical
urticaria did not seem to provoke HAE. These findings
are emphasizing that mechanisms in AIU are different
compared to acute or physical urticaria. In AIU most
probably activated mast cells are involved but the exact
pathomechanism is still not clear [31]. The drugs ASS,
ASS combinations and Paroxetin® provoked peripheral, fa-
cial and abdominal angioedema. According to the negative
skin test results, non IgE-mediated hypersensitivity
reaction (e.g. pseudoallergy) most probably induced the
symptoms [32, 33]. Further investigations are required to
analyze the threshold of mast cell activation in the
different subtypes of urticaria and pseudoallergy with a
subsequent potential to induce the contact activation
pathway with bradykinin release.
Two patients who stated a local reaction and an ab-
dominal angioedema attack induced by hymenoptera
stings, showed no sensitization to the major allergens
rApi m1/10 and rVes v5 involved. In these patients, it
was not allergy, but rather the pain of the sting and the
stress that triggered the angioedema attacks.
Severe IgE-mediated hypersensitivity reactions most
probably can induce bradykinergic angioedema attacks
by induction of the contact activation pathway [12, 13].
Therefore if HAE affected subjects indicate triggers such
as food, hymenoptera stings or drugs, which have the
potential to induce severe IgE-mediated hypersensitivity
reaction, specific IgE antibodies must be excluded. How-
ever intolerance reactions seem to be more important
triggers than IgE-mediated mechanisms.
Strength and limitations
To our knowledge this is the first study that addresses
food as a trigger factor in patients with HAE. Although
the selected cohort is small, we consider the results
valid. Self-reporting of trigger factors and symptoms
carry the risk of reporting bias. A downside of this study
is that no provocation tests with the incriminated food,
suspected drug or a challenge sting test with a living
hymenoptera has been performed.
Conclusion
Food products can be important trigger factors for abdom-
inal angioedema attacks in HAE. The underlying pathome-
chanism most often is compatible with an intolerance
reaction. IgE-mediated hypersensitivity reactions seem
rarely cause angioedema in HAE. Studying trigger factors
in HAE is essential to obtain a better understanding of the
disease mechanisms.
Table 3 Frequency and distribution of attacks per year stratified for male vs female and atopy vs non-atopy
Female (n = 27) * p-value Male (n = 15)
No atopy (n = 18) Atopy (n = 9) No atopy (n = 12) Atopy (n = 3)
No attacks (# subjects) 2 1 5 3
Rare attacks (# subjects) 4 2 0.029 5 -
# attacks (range) 1.5 (1–3) 4 (4–4) 4 (2–6) -
Moderate attacks (# subjects) 8 5 0.854 2 -
# attacks (range) 25.1 (15–37) 26 (12–36) 12 (12–12) -
Frequent attacks (# subjects) 4 1 - -
# attacks (range) 89.5 (53–136) 93 - -
* t-test: The p-values are for the comparison of attack frequency among atopic and non-atopic subjects within one specific category of attacks, where feasible
no attacks: < 1/year; rare attacks: < 1/month; ≥ 1/year; moderate attacks: < 1/week; ≥ 1/month; frequent attacks: ≥1/week
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